Frontiers Progress in the study of oxidative stress damage in patients with schizophrenia: challenges and opportunities Some patients with schizophrenia like symptoms may have a treatable, immune mediated illnessand early immunotherapy can drastically change outcomes., Katlyn Nemani, MD, is challenging how we think Brain glutathione levels and age at onset of illness in chronic schizophrenia Acta Neuropsychiatrica Cambridge Core Early treatment response in first episode psychosis: a 7 T magnetic resonance spectroscopic study of glutathione and glutamate Molecular Psychiatry